Notably, NK-exos exhibit strong therapeutic effects and precise targeting through cytotoxic proteins (e.g., granzyme B and perforin), effectively killing tumors in various cancers [15,16,17,18,19,20]. This evidence concerns the gene PRF1 and cancer.